MX2014013851A - Composiciones farmaceuticas topicas que comprenden terbinafina y urea. - Google Patents

Composiciones farmaceuticas topicas que comprenden terbinafina y urea.

Info

Publication number
MX2014013851A
MX2014013851A MX2014013851A MX2014013851A MX2014013851A MX 2014013851 A MX2014013851 A MX 2014013851A MX 2014013851 A MX2014013851 A MX 2014013851A MX 2014013851 A MX2014013851 A MX 2014013851A MX 2014013851 A MX2014013851 A MX 2014013851A
Authority
MX
Mexico
Prior art keywords
terbinafine
urea
topical pharmaceutical
pharmaceutical compositions
composition
Prior art date
Application number
MX2014013851A
Other languages
English (en)
Inventor
Henning Mallwitz
Christoph Willers
Sabine Fielhauer
Dirk-Heinrich Evers
Sascha Gorissen
Michael Herbig
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46148606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014013851(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of MX2014013851A publication Critical patent/MX2014013851A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que comprende, con base en el peso total de la composición: a) de 1.5% en peso a 5% en peso de terbinafina o cualquier sal farmacéuticamente aceptable de la misma; b) de 15 % en peso a 35 % en peso de urea; y c) más que 25 % en peso de agua.
MX2014013851A 2012-05-14 2013-05-13 Composiciones farmaceuticas topicas que comprenden terbinafina y urea. MX2014013851A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646650P 2012-05-14 2012-05-14
EP20120003791 EP2664327A1 (en) 2012-05-14 2012-05-14 Topical pharmaceutical compositions comprising terbinafide and urea
PCT/EP2013/059814 WO2013171159A1 (en) 2012-05-14 2013-05-13 Topical pharmaceutical compositions comprising terbinafine and urea

Publications (1)

Publication Number Publication Date
MX2014013851A true MX2014013851A (es) 2015-02-12

Family

ID=46148606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013851A MX2014013851A (es) 2012-05-14 2013-05-13 Composiciones farmaceuticas topicas que comprenden terbinafina y urea.

Country Status (20)

Country Link
US (1) US20150111971A1 (es)
EP (2) EP2664327A1 (es)
JP (1) JP2015516455A (es)
KR (1) KR20150013162A (es)
CN (1) CN104302281A (es)
AR (1) AR091039A1 (es)
AU (1) AU2013261918A1 (es)
BR (1) BR112014028280A2 (es)
CA (1) CA2872210A1 (es)
CL (1) CL2014003081A1 (es)
CO (1) CO7131352A2 (es)
EA (1) EA201492091A1 (es)
HK (1) HK1202808A1 (es)
IL (1) IL235241A0 (es)
MX (1) MX2014013851A (es)
PH (1) PH12014502512A1 (es)
SG (1) SG11201407536UA (es)
TW (1) TW201350107A (es)
WO (1) WO2013171159A1 (es)
ZA (1) ZA201407655B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
SI3209319T1 (sl) 2014-10-21 2022-01-31 Hexima Limited Postopek zdravljenja glivičnih okužb
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
JP7012089B2 (ja) * 2017-02-15 2022-01-27 ボタニクス ファーマシューティカルズ リミテッド 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤
EP3492068A1 (en) 2017-12-01 2019-06-05 NCP NewCare Products GmbH Composition for treating onychomycosis
WO2019214838A1 (en) * 2018-05-09 2019-11-14 Eviderm Institute Ab Use of an alcohol-containing composition for improving the skin barrier function
PL245223B1 (pl) * 2019-01-10 2024-06-03 Biotts Spółka Akcyjna Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna go zawierająca
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
WO2024038427A1 (en) * 2022-08-17 2024-02-22 Lyotropic Delivery Systems Ltd. Topical delivery of antifungal agents for treating fungal infections
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
EP2544659A2 (en) * 2009-12-23 2013-01-16 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis

Also Published As

Publication number Publication date
KR20150013162A (ko) 2015-02-04
EA201492091A1 (ru) 2015-03-31
CN104302281A (zh) 2015-01-21
CO7131352A2 (es) 2014-12-01
EP2664327A1 (en) 2013-11-20
CA2872210A1 (en) 2013-11-21
BR112014028280A2 (pt) 2019-09-24
SG11201407536UA (en) 2014-12-30
HK1202808A1 (en) 2015-10-09
TW201350107A (zh) 2013-12-16
IL235241A0 (en) 2014-12-31
PH12014502512A1 (en) 2014-12-22
CL2014003081A1 (es) 2015-03-27
AU2013261918A1 (en) 2014-11-06
US20150111971A1 (en) 2015-04-23
EP2849739A1 (en) 2015-03-25
ZA201407655B (en) 2015-06-24
AR091039A1 (es) 2014-12-30
WO2013171159A1 (en) 2013-11-21
JP2015516455A (ja) 2015-06-11

Similar Documents

Publication Publication Date Title
MX2014013851A (es) Composiciones farmaceuticas topicas que comprenden terbinafina y urea.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX354102B (es) Derivados de bencimidazol-prolina.
MX2013001677A (es) Formulaciones estables de linaclotida.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
PH12016501122A1 (en) Delayed release compositions of linaclotide
JO3154B1 (ar) عوامل مضادة لـ trpv4
JOP20130342B1 (ar) تكوين ثابت من بيميتركس
IN2014DN10670A (es)
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12015502632A1 (en) Cxcr7 receptor modulators
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
MX2013013079A (es) Composiciones que comprenden un agente antibacterial y tazobactam.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
TR201103691A2 (tr) Deferasiroks dağılabilir tablet formülasyonu.
MX2011009844A (es) Composicion farmaceutica que comprende alisquireno.
IN2013DE00880A (es)
UA112586C2 (uk) Похідні бензімідазолпроліну
UA105703C2 (uk) 7-бром-5-феніл-3-ариламіно-1,2-дигідро-3н-1,4-бенздіазепін-2-они як анальгетичні агенти
IN2013MU01152A (es)